Načítá se...
Oral Anticoagulation in Chronic Kidney Disease and Atrial Fibrillation: The Use of Non-Vitamin K-Dependent Anticoagulants and Vitamin K Antagonists
BACKGROUND: Cardiological societies recommend, in their guidelines, that patients with atrial fibrillation and an intermediate (or higher) risk of stroke and systemic embolization should be treated with oral anticoagulant drugs. For patients who do not have mitral valve stenosis or a mechanical valv...
Uloženo v:
| Vydáno v: | Dtsch Arztebl Int |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Deutscher Arzte Verlag
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5974258/ https://ncbi.nlm.nih.gov/pubmed/29789105 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3238/arztebl.2018.0287 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|